University of Birmingham NHS Foundation Trust

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors	Solid Tumor, Adult	Recruiting	Phase 1 / Phase 2	2026-01-08		NCT06265727
Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)	Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 2	2024-12-05		NCT02406222

Clinical trials